Invention Grant
- Patent Title: Azaindoles for inhibiting aurora2 and other kinases
- Patent Title (中): 抑制极光2和其他激酶的阿魏酸
-
Application No.: US10995103Application Date: 2004-11-23
-
Publication No.: US07943616B2Publication Date: 2011-05-17
- Inventor: Paul J. Cox , Tahir N. Majid , Justine Yeun Quai Lai , Andrew D. Morley , Shelley Amendola , Stephanie D. Deprets , Christopher Edlin , Charles J. Gardner , Dorothea Kominos , Brian L. Pedgrift , Frank Halley , Timothy A. Gillespy , Michael Edwards , Francois F. Clerc , Conception Nemecek , Olivier Houille , Dominique Damour , Herve Bouchard , Daniel N. A. Bezard , Chantal Carrez
- Applicant: Paul J. Cox , Tahir N. Majid , Justine Yeun Quai Lai , Andrew D. Morley , Shelley Amendola , Stephanie D. Deprets , Christopher Edlin , Charles J. Gardner , Dorothea Kominos , Brian L. Pedgrift , Frank Halley , Timothy A. Gillespy , Michael Edwards , Francois F. Clerc , Conception Nemecek , Olivier Houille , Dominique Damour , Herve Bouchard , Daniel N. A. Bezard , Chantal Carrez
- Applicant Address: US NJ Bridgewater
- Assignee: Aventis Pharmaceuticals Inc.
- Current Assignee: Aventis Pharmaceuticals Inc.
- Current Assignee Address: US NJ Bridgewater
- Agent Jiang Lin
- Priority: GB0115109.1 20010621
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/5025 ; A61P29/00 ; A61P35/00 ; A61P19/02
Abstract:
The invention is directed to physiologically active compounds of general formula (I):— and compositions containing such compounds; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.
Public/Granted literature
- US20050267304A1 Azaindoles Public/Granted day:2005-12-01
Information query
